Quantcast

Latest Dabigatran Stories

2014-06-03 23:14:55

German pharmaceutical company Boehringer Ingelheim GmbH has agreed to settle thousands of claims against the drug manufacturer for injuries and deaths caused by the blood thinner Pradaxa. Columbus, Ohio (PRWEB) June 03, 2014 O’Connor, Acciani & Levy, an Ohio pharmaceutical litigation firm, continue to investigate claims regarding Pradaxa, a blood thinner manufactured by German pharmaceutical company Boehringer Ingelheim GmbH. According to a Bloomberg report published on May 28,...

2014-05-31 23:04:13

Greg Coleman Law reviews the impact of Boehringer’s settlement offer and the drugmaker’s motivations in light of the more than 4,000 pending Pradaxa lawsuits in U.S. courts. Knoxville, TN (PRWEB) May 31, 2014 Greg Coleman Law, a Tennessee defective drug litigation law firm, continues to express concerns about the proposed Pradaxa litigation settlement announced by Boehringer Ingelheim GmbH on May 28, 2014. The firm continues to review and investigate claims that the blood thinner...

2014-05-29 23:15:58

Boehringer Ingelheim Agrees to Pay $650 Million To Settle 4,000 Pradaxa Lawsuit That Allege Internal Bleeding After Taking The Prescription Medication. Columbus, OH (PRWEB) May 29, 2014 Wright & Schulte LLC, an experienced personal injury law firm representing plaintiffs in Pradaxa lawsuits pending in federal court, reports that Boehringer Ingelheim has agreed to pay $650 million to settle Pradaxa lawsuits filed on behalf of plaintiffs who allegedly experienced serious internal...

2014-05-28 23:02:26

The Firm is evaluating Pradaxa bleeding claims on behalf of individuals who allegedly suffered life-threatening episodes of internal hemorrhaging due to their use of Pradaxa. New York, New York (PRWEB) May 28, 2014 As Pradaxa lawsuits (http://www.pradaxalawsuithelp.com/) continue to mount in federal court, Bernstein Liebhard LLP notes that the manufacturer of the blood thinner has acknowledged that a number of serious bleeding events were omitted from the original report on a clinical...

2014-05-28 23:01:48

Seth A. Katz and Burg Simpson Eldredge Hersh & Jardine, P.C. are pleased to announce that earlier today Boehringer Ingelheim Pharmaceuticals, Inc. and its related companies agreed to pay $650,000,000 to settle close to 4,000 claims brought on behalf of individuals who were injured after taking the company’s anticoagulant drug, Pradaxa (dabigatran etexilate). (PRWEB) May 28, 2014 Denver, Colorado: Seth A. Katz and Burg Simpson Eldredge Hersh & Jardine, P.C. are pleased to...

2014-05-28 08:31:29

RIDGEFIELD, Conn., May 28, 2014 /PRNewswire/ -- Boehringer Ingelheim (BI) announced today that it has reached a comprehensive settlement of state and federal cases in the U.S. litigation regarding Pradaxa® (dabigatran etexilate mesylate) in the amount of $650 million. "Time and again, the benefits and safety of PRADAXA have been confirmed," said Desiree Ralls-Morrison, senior vice president and general counsel, Boehringer Ingelheim USA Corporation. "BI stands resolutely behind PRADAXA and...

2014-05-23 23:09:43

Ashley Brittain Landers of Schlichter, Bogard & Denton, LLP reports that the FDA has issued a new safety announcement regarding the increased risk of major gastrointestinal (GI) bleeding associated with Pradaxa in comparison to warfarin. The attorneys at Schlichter, Bogard & Denton, LLP are offering free and confidential case reviews to those who allege to have been injured after using Pradaxa. St. Louis, MO (PRWEB) May 23, 2014 On May 13, 2014, the FDA issued a Safety...

2014-05-18 23:01:24

The Firm is investigating legal claims on behalf of alleged victims of Pradaxa bleeding side effects. New York, New York (PRWEB) May 18, 2014 Thousands of Pradaxa lawsuits (http://www.pradaxalawsuithelp.com/) filed on behalf of patients who allegedly suffered life-threatening internal bleeding due to the drug continue to move forward in a multidistrict litigation underway in U.S. District Court, Southern District of Illinois, Bernstein Liebhard LLP reports. According to an Order issued...

2014-05-16 23:09:35

On May 13, the FDA announced that Pradaxa is associated with a lower risk of clot-related strokes, bleeding in the brain, and death and with an increased risk of major gastrointestinal bleeding compared to warfarin. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) May 16, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information...

2014-05-14 23:03:07

The Firm is evaluating Pradaxa lawsuits on behalf of individuals who allegedly suffered serious gastrointestinal hemorrhaging and other episodes of uncontrollable internal bleeding due to Pradaxa. New York, New York (PRWEB) May 14, 2014 As Pradaxa lawsuits (http://www.pradaxalawsuithelp.com/) continue to mount in U.S. courts, Bernstein Liebhard LLP notes that the U.S. Food & Drug Administration (FDA) has issued a new Drug Safety Communication pertaining to the blood-thinning drug....


Word of the Day
attercop
  • A spider.
  • Figuratively, a peevish, testy, ill-natured person.
'Attercop' comes from the Old English 'atorcoppe,' where 'atter' means 'poison, venom' and‎ 'cop' means 'spider.' 'Coppa' is a derivative of 'cop,' top, summit, round head, or 'copp,' cup, vessel, which refers to 'the supposed venomous properties of spiders,' says the OED. 'Copp' is still found in the word 'cobweb.'
Related